Eschler Asset Management LLP acquired a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 1,910 shares of the company’s stock, valued at approximately $892,000.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. State Street Corp raised its holdings in shares of HCA Healthcare by 1.0% in the fourth quarter. State Street Corp now owns 7,566,643 shares of the company’s stock worth $3,532,563,000 after buying an additional 76,039 shares during the period. Capital World Investors raised its holdings in shares of HCA Healthcare by 0.8% in the fourth quarter. Capital World Investors now owns 4,999,422 shares of the company’s stock worth $2,334,040,000 after buying an additional 40,086 shares during the period. Geode Capital Management LLC raised its holdings in shares of HCA Healthcare by 0.4% in the fourth quarter. Geode Capital Management LLC now owns 3,663,705 shares of the company’s stock worth $1,702,738,000 after buying an additional 13,565 shares during the period. Norges Bank purchased a new stake in shares of HCA Healthcare in the fourth quarter worth approximately $1,262,513,000. Finally, Arrowstreet Capital Limited Partnership raised its holdings in shares of HCA Healthcare by 11.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after buying an additional 245,887 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Ratings Changes
HCA has been the topic of several research analyst reports. Stephens dropped their price objective on HCA Healthcare from $560.00 to $530.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Wall Street Zen cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Jefferies Financial Group reissued a “buy” rating and issued a $525.00 price objective on shares of HCA Healthcare in a research note on Friday, April 24th. Barclays dropped their price objective on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating on the stock in a research note on Monday, April 27th. Finally, TD Cowen dropped their target price on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating on the stock in a research report on Monday, April 27th. Fifteen analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, HCA Healthcare presently has a consensus rating of “Moderate Buy” and an average price target of $506.14.
HCA Healthcare Trading Up 2.3%
Shares of NYSE HCA opened at $387.25 on Friday. The stock has a market capitalization of $85.91 billion, a PE ratio of 13.32, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52. The stock’s fifty day simple moving average is $429.60 and its two-hundred day simple moving average is $473.48.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings data on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). The business had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the previous year, the business earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities analysts predict that HCA Healthcare, Inc. will post 30.07 earnings per share for the current fiscal year.
HCA Healthcare Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be given a $0.78 dividend. The ex-dividend date of this dividend is Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.
HCA Healthcare Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
Featured Stories
- Five stocks we like better than HCA Healthcare
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
